Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5896510 | Best Practice & Research Clinical Endocrinology & Metabolism | 2015 | 13 Pages |
Abstract
The lysosomal storage disorders (LSDs) are a group of genetic disorders resulting from defective lysosomal metabolism and subsequent accumulation of substrates. Patients present with a large phenotypic spectrum of disease manifestations that are generally not specific for LSDs, leading to considerable diagnostic delay and missed cases. Introduction of new disease modifying therapies for LSDs has made early diagnosis a priority. Increased awareness, but particularly the introduction of screening programs allow for early diagnosis and timely initiation of treatment. This review will provide insight into the epidemiology and diagnostic process for LSDs. In addition, challenges for carrier screening, high-risk screening and newborn population screening for LSDs are discussed.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Sandra D.K. (PhD Student), Olaf A. (Clinical Professor of Pediactrics), Frits A. (Professor of Pediatrics),